Utah Medical Products, Inc. (UTMD)
USD 62.0
(-0.85%)
USD 62.0
(-0.85%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7.14 Million USD | -25.72% |
| 2022 | 9.61 Million USD | 14.2% |
| 2021 | 8.42 Million USD | -5.6% |
| 2020 | 8.92 Million USD | 2.62% |
| 2019 | 8.69 Million USD | -19.31% |
| 2018 | 10.77 Million USD | -26.31% |
| 2017 | 14.62 Million USD | 99.22% |
| 2016 | 7.34 Million USD | -22.96% |
| 2015 | 9.52 Million USD | -42.33% |
| 2014 | 16.52 Million USD | -17.93% |
| 2013 | 20.13 Million USD | -22.47% |
| 2012 | 25.96 Million USD | -27.14% |
| 2011 | 35.63 Million USD | 934.04% |
| 2010 | 3.44 Million USD | -8.67% |
| 2009 | 3.77 Million USD | -6.07% |
| 2008 | 4.01 Million USD | -44.19% |
| 2007 | 7.19 Million USD | -10.84% |
| 2006 | 8.07 Million USD | -8.12% |
| 2005 | 8.78 Million USD | 72.09% |
| 2004 | 5.1 Million USD | -61.21% |
| 2003 | 13.16 Million USD | 71.72% |
| 2002 | 7.66 Million USD | 42.87% |
| 2001 | 5.36 Million USD | -58.97% |
| 2000 | 13.07 Million USD | 45.82% |
| 1999 | 8.96 Million USD | 49.45% |
| 1998 | 6 Million USD | -32.58% |
| 1997 | 8.9 Million USD | 97.78% |
| 1996 | 4.5 Million USD | 9.76% |
| 1995 | 4.1 Million USD | 2.5% |
| 1994 | 4 Million USD | 14.29% |
| 1993 | 3.5 Million USD | 12.9% |
| 1992 | 3.1 Million USD | -18.42% |
| 1991 | 3.8 Million USD | -7.32% |
| 1990 | 4.1 Million USD | -16.33% |
| 1989 | 4.9 Million USD | 36.11% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 7.69 Million USD | 7.75% |
| 2024 Q3 | 5.49 Million USD | -8.08% |
| 2024 Q2 | 5.98 Million USD | -22.33% |
| 2023 Q2 | 8.71 Million USD | -10.65% |
| 2023 Q4 | 7.14 Million USD | -5.25% |
| 2023 Q3 | 7.54 Million USD | -13.45% |
| 2023 Q1 | 9.75 Million USD | 1.38% |
| 2023 FY | 7.14 Million USD | -25.72% |
| 2022 Q3 | 10.22 Million USD | 17.85% |
| 2022 Q1 | 10.63 Million USD | 26.26% |
| 2022 FY | 9.61 Million USD | 14.2% |
| 2022 Q4 | 9.61 Million USD | -5.95% |
| 2022 Q2 | 8.67 Million USD | -18.4% |
| 2021 Q1 | 9.5 Million USD | 6.52% |
| 2021 Q2 | 9.42 Million USD | -0.8% |
| 2021 Q4 | 8.42 Million USD | -13.8% |
| 2021 FY | 8.42 Million USD | -5.6% |
| 2021 Q3 | 9.77 Million USD | 3.64% |
| 2020 FY | 8.92 Million USD | 2.62% |
| 2020 Q1 | 8.8 Million USD | 1.3% |
| 2020 Q2 | 8.25 Million USD | -6.26% |
| 2020 Q3 | 8.65 Million USD | 4.84% |
| 2020 Q4 | 8.92 Million USD | 3.07% |
| 2019 Q3 | 9.1 Million USD | -3.6% |
| 2019 Q2 | 9.44 Million USD | -26.62% |
| 2019 Q1 | 12.87 Million USD | 19.49% |
| 2019 FY | 8.69 Million USD | -19.31% |
| 2019 Q4 | 8.69 Million USD | -4.53% |
| 2018 Q2 | 13.68 Million USD | -5.65% |
| 2018 Q4 | 10.77 Million USD | 4.41% |
| 2018 Q3 | 10.32 Million USD | -24.57% |
| 2018 FY | 10.77 Million USD | -26.31% |
| 2018 Q1 | 14.5 Million USD | -0.83% |
| 2017 Q1 | 9.62 Million USD | 31.19% |
| 2017 FY | 14.62 Million USD | 99.22% |
| 2017 Q4 | 14.62 Million USD | 54.28% |
| 2017 Q3 | 9.47 Million USD | 9.04% |
| 2017 Q2 | 8.69 Million USD | -9.73% |
| 2016 Q2 | 9.97 Million USD | -13.7% |
| 2016 Q3 | 10.14 Million USD | 1.72% |
| 2016 Q4 | 7.34 Million USD | -27.64% |
| 2016 Q1 | 11.55 Million USD | 21.29% |
| 2016 FY | 7.34 Million USD | -22.96% |
| 2015 Q2 | 11.73 Million USD | 1.76% |
| 2015 FY | 9.52 Million USD | -42.33% |
| 2015 Q1 | 11.53 Million USD | -30.18% |
| 2015 Q4 | 9.52 Million USD | -19.28% |
| 2015 Q3 | 11.8 Million USD | 0.55% |
| 2014 FY | 16.52 Million USD | -17.93% |
| 2014 Q4 | 16.52 Million USD | -8.54% |
| 2014 Q2 | 19.32 Million USD | -3.16% |
| 2014 Q1 | 19.95 Million USD | -0.86% |
| 2014 Q3 | 18.06 Million USD | -6.53% |
| 2013 FY | 20.13 Million USD | -22.47% |
| 2013 Q3 | 23.52 Million USD | -1.11% |
| 2013 Q2 | 23.78 Million USD | -7.24% |
| 2013 Q1 | 25.64 Million USD | -1.22% |
| 2013 Q4 | 20.13 Million USD | -14.42% |
| 2012 Q2 | 31.33 Million USD | -11.58% |
| 2012 FY | 25.96 Million USD | -27.14% |
| 2012 Q3 | 30.09 Million USD | -3.95% |
| 2012 Q1 | 35.43 Million USD | -0.55% |
| 2012 Q4 | 25.96 Million USD | -13.73% |
| 2011 Q4 | 35.63 Million USD | -7.91% |
| 2011 Q3 | 38.69 Million USD | -5.1% |
| 2011 FY | 35.63 Million USD | 934.04% |
| 2011 Q1 | 43.51 Million USD | 1162.62% |
| 2011 Q2 | 40.77 Million USD | -6.3% |
| 2010 FY | 3.44 Million USD | -8.67% |
| 2010 Q1 | 5.13 Million USD | 36.07% |
| 2010 Q2 | 4.1 Million USD | -20.12% |
| 2010 Q3 | 4.43 Million USD | 8.07% |
| 2010 Q4 | 3.44 Million USD | -22.25% |
| 2009 Q1 | 5.39 Million USD | 34.2% |
| 2009 Q3 | 4.88 Million USD | 13.75% |
| 2009 Q4 | 3.77 Million USD | -22.83% |
| 2009 Q2 | 4.29 Million USD | -20.27% |
| 2009 FY | 3.77 Million USD | -6.07% |
| 2008 Q2 | 6.41 Million USD | -18.7% |
| 2008 FY | 4.01 Million USD | -44.19% |
| 2008 Q1 | 7.88 Million USD | 9.62% |
| 2008 Q3 | 5.81 Million USD | -9.28% |
| 2008 Q4 | 4.01 Million USD | -30.97% |
| 2007 Q4 | 7.19 Million USD | -9.44% |
| 2007 FY | 7.19 Million USD | -10.84% |
| 2007 Q2 | 7.61 Million USD | -13.56% |
| 2007 Q3 | 7.94 Million USD | 4.43% |
| 2007 Q1 | 8.8 Million USD | 9.07% |
| 2006 Q3 | 8.41 Million USD | 2.26% |
| 2006 Q1 | 8.35 Million USD | -4.88% |
| 2006 Q2 | 8.22 Million USD | -1.58% |
| 2006 Q4 | 8.07 Million USD | -4.02% |
| 2006 FY | 8.07 Million USD | -8.12% |
| 2005 Q2 | 3.36 Million USD | -26.42% |
| 2005 Q4 | 8.78 Million USD | 152.08% |
| 2005 FY | 8.78 Million USD | 72.09% |
| 2005 Q3 | 3.48 Million USD | 3.57% |
| 2005 Q1 | 4.57 Million USD | -10.42% |
| 2004 Q3 | 5.01 Million USD | -8.17% |
| 2004 Q4 | 5.1 Million USD | 1.9% |
| 2004 Q1 | 8.1 Million USD | -38.46% |
| 2004 FY | 5.1 Million USD | -61.21% |
| 2004 Q2 | 5.45 Million USD | -32.64% |
| 2003 FY | 13.16 Million USD | 71.72% |
| 2003 Q1 | 6.13 Million USD | -19.93% |
| 2003 Q2 | 4.1 Million USD | -33.19% |
| 2003 Q4 | 13.16 Million USD | 468.06% |
| 2003 Q3 | 2.31 Million USD | -43.49% |
| 2002 Q4 | 7.66 Million USD | 237.81% |
| 2002 FY | 7.66 Million USD | 42.87% |
| 2002 Q1 | 3.96 Million USD | -26.06% |
| 2002 Q2 | 2.34 Million USD | -40.89% |
| 2002 Q3 | 2.26 Million USD | -3.24% |
| 2001 Q1 | 10.95 Million USD | -16.23% |
| 2001 Q4 | 5.36 Million USD | -27.87% |
| 2001 Q3 | 7.43 Million USD | -20.24% |
| 2001 Q2 | 9.32 Million USD | -14.87% |
| 2001 FY | 5.36 Million USD | -58.97% |
| 2000 Q1 | 8.03 Million USD | -10.4% |
| 2000 Q4 | 13.07 Million USD | -13.21% |
| 2000 Q2 | 7.05 Million USD | -12.16% |
| 2000 FY | 13.07 Million USD | 45.82% |
| 2000 Q3 | 15.06 Million USD | 113.49% |
| 1999 Q4 | 8.96 Million USD | -20.65% |
| 1999 FY | 8.96 Million USD | 49.45% |
| 1999 Q2 | 4.1 Million USD | -14.58% |
| 1999 Q3 | 11.3 Million USD | 175.61% |
| 1999 Q1 | 4.8 Million USD | -20.0% |
| 1998 Q3 | 8.8 Million USD | 46.67% |
| 1998 Q4 | 6 Million USD | -31.82% |
| 1998 FY | 6 Million USD | -32.58% |
| 1998 Q2 | 6 Million USD | -21.05% |
| 1998 Q1 | 7.6 Million USD | -14.61% |
| 1997 FY | 8.9 Million USD | 97.78% |
| 1997 Q1 | 4.7 Million USD | 4.44% |
| 1997 Q2 | 6 Million USD | 27.66% |
| 1997 Q3 | 11.7 Million USD | 95.0% |
| 1997 Q4 | 8.9 Million USD | -23.93% |
| 1996 Q3 | 4.3 Million USD | 13.16% |
| 1996 Q2 | 3.8 Million USD | -26.92% |
| 1996 Q1 | 5.2 Million USD | 26.83% |
| 1996 Q4 | 4.5 Million USD | 4.65% |
| 1996 FY | 4.5 Million USD | 9.76% |
| 1995 Q4 | 4.1 Million USD | -2.38% |
| 1995 Q1 | 4.1 Million USD | 2.5% |
| 1995 Q2 | 3.6 Million USD | -12.2% |
| 1995 Q3 | 4.2 Million USD | 16.67% |
| 1995 FY | 4.1 Million USD | 2.5% |
| 1994 Q3 | 3.2 Million USD | -8.57% |
| 1994 Q4 | 4 Million USD | 25.0% |
| 1994 Q1 | 4 Million USD | 14.29% |
| 1994 FY | 4 Million USD | 14.29% |
| 1994 Q2 | 3.5 Million USD | -12.5% |
| 1993 Q3 | 3.4 Million USD | 6.25% |
| 1993 Q2 | 3.2 Million USD | -23.81% |
| 1993 Q1 | 4.2 Million USD | 35.48% |
| 1993 Q4 | 3.5 Million USD | 2.94% |
| 1993 FY | 3.5 Million USD | 12.9% |
| 1992 Q2 | 4.1 Million USD | -6.82% |
| 1992 Q1 | 4.4 Million USD | 15.79% |
| 1992 FY | 3.1 Million USD | -18.42% |
| 1992 Q4 | 3.1 Million USD | -20.51% |
| 1992 Q3 | 3.9 Million USD | -4.88% |
| 1991 Q1 | 4.2 Million USD | 2.44% |
| 1991 FY | 3.8 Million USD | -7.32% |
| 1991 Q2 | 3.8 Million USD | -9.52% |
| 1991 Q3 | 4 Million USD | 5.26% |
| 1991 Q4 | 3.8 Million USD | -5.0% |
| 1990 Q3 | 4.4 Million USD | -8.33% |
| 1990 Q4 | 4.1 Million USD | -6.82% |
| 1990 Q2 | 4.8 Million USD | -2.04% |
| 1990 Q1 | 4.9 Million USD | 0.0% |
| 1990 FY | 4.1 Million USD | -16.33% |
| 1989 FY | 4.9 Million USD | 36.11% |
| 1989 Q2 | 3.4 Million USD | 0.0% |
| 1989 Q3 | 4.5 Million USD | 32.35% |
| 1989 Q4 | 4.9 Million USD | 8.89% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 94.356% |
| AngioDynamics, Inc. | 112.08 Million USD | 93.625% |
| AtriCure, Inc. | 147.76 Million USD | 95.165% |
| Avinger, Inc. | 19.97 Million USD | 64.225% |
| Azenta, Inc. | 351.22 Million USD | 97.966% |
| BioLife Solutions, Inc. | 75.05 Million USD | 90.48% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.826% |
| Daxor Corporation | 858.75 Thousand USD | -732.016% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | 56.198% |
| Femasys Inc. | 9.4 Million USD | 24.016% |
| GlucoTrack, Inc. | 1.7 Million USD | -318.326% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 88.887% |
| Hologic, Inc. | 4.02 Billion USD | 99.823% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.683% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 99.65% |
| KORU Medical Systems, Inc. | 8.1 Million USD | 11.868% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 85.382% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -982.681% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -982.681% |
| Masimo Corporation | 1.67 Billion USD | 99.574% |
| Microbot Medical Inc. | 3.82 Million USD | -86.749% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | 71.508% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 99.364% |
| Nephros, Inc. | 3.5 Million USD | -103.968% |
| NovoCure Limited | 783.63 Million USD | 99.088% |
| NEXGEL, Inc. | 4.78 Million USD | -49.196% |
| NEXGEL, Inc. | 4.78 Million USD | -49.196% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 91.736% |
| OraSure Technologies, Inc. | 52.17 Million USD | 86.305% |
| Pro-Dex, Inc. | 23.34 Million USD | 69.391% |
| Pulse Biosciences, Inc. | 16.44 Million USD | 56.549% |
| Predictive Oncology Inc. | 6.14 Million USD | -16.265% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -4.386% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.799% |
| Repligen Corporation | 853.2 Million USD | 99.163% |
| Sanara MedTech Inc. | 29.28 Million USD | 75.6% |
| STAAR Surgical Company | 102.73 Million USD | 93.045% |
| Sharps Technology, Inc. | 3.85 Million USD | -85.345% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.825% |
| Jin Medical International Ltd. | 8.92 Million USD | 19.938% |